1999

Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary artery disease, today announced that it has received CE Mark approval for its ACS MULTI-LINK...

Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiovascular and vascular therapy, announced today that the Circulatory System Devices Panel of the Medical Devices...

Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a worldwide leader in cardiac rhythm management systems, today announced the U.S. market release of the PULSAR(tm) and PULSAR MAX...

Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary artery disease, today announced that it has received CE Mark approval for the ACS MULTI-LINK...

Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiovascular therapy, announced that at the company(tm)s Annual Meeting of Shareholders on , Guidant(tm)s...

Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a worldwide leader in cardiac rhythm management systems, today announced two corporate initiatives in support of the Multicenter...

Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a worldwide leader in implantable defibrillation systems, today announced the U.S. market release of the VENTAK® VR AICD(tm) Automatic...

Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT) today announced that its Board of Directors has elected Michael Grobstein as a director of Guidant effective immediately. The appointment...

Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a worldwide leader in cardiac rhythm management systems, today announced the first two implants of the CONTAK(tm) TR Congestive Heart...